Amy L. Burroughs

CIK 1872564 · Chief Executive Officer · last filed 2026-05-29

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$414.1K

Companies

3

Total Filings

19

Lifetime Open-Market Net

-$6.17M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TNYA Director $0.71 $0 5 2026-05-29
Terns Pharmaceuticals, Inc. (TERN) Delisted Chief Executive Officer 0 $52.95 $0 -$6.32M 9 2026-05-05
DMAC Director 73,288 $5.65 $414.1K $141.6K 5 2023-01-03

Recent Filings · Page 2 of 2

19 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-10-21 TNYA Grant (A) $0 EDGAR
2024-03-05 Terns Pharmaceuticals, Inc. (TERN) Delisted Grant (A) $0 EDGAR
2023-06-12 TNYA Grant (A) $0 EDGAR
2023-01-03 DMAC Grant (A) +17,156 $26.2K EDGAR
2022-12-07 TNYA Grant (A) $0 EDGAR
2022-06-02 DMAC Grant (A) $0 EDGAR
2022-01-03 DMAC Grant (A) +11,182 $40.0K EDGAR
2021-08-17 DMAC Buy (P) +44,950 $141.6K EDGAR
2021-07-16 DMAC Grant (A) $0 EDGAR
Showing 1119 of 19
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.